Ross Muken

Ross Muken is a highly accomplished professional with a solid educational background and extensive experience in finance and management.

He earned a Bachelor's Degree in Business Administration and Management, General, with an impressive GPA of 3.7 from Boston University.

Currently, Ross Muken serves as the Chief Financial Officer at SOPHiA GENETICS, where he plays a key role in financial management and strategic decision-making.

Prior to his current role, he was a Strategic Advisor at Osmind, showcasing his versatility and adaptability in different organizational settings.

Ross Muken has also held significant positions at other prominent organizations, including being the Chief Financial Officer and Chief Operating Officer at Click Therapeutics, Inc.

His expertise extends to the financial sector, as evidenced by his roles as Senior Managing Director & Partner, Equity Research at Evercore, Managing Director at Deutsche Bank, and Vice President Equity Research at the same institution.

Ross Muken's early career includes valuable experience as an Equity Research Associate at Thomas Weisel Partners and a Mergers & Acquisitions Analyst at Bank of America.

His rich professional journey demonstrates his diverse skill set and strong foundation in finance and business management.

Ross Muken's contributions have made a significant impact on each organization he has been a part of, highlighting his strategic thinking and financial acumen.

With a proven track record of leadership and expertise in finance, Ross Muken continues to make substantial contributions to the industry.